ABCA1 p.Thr1243Ala

[switch to full view]
Comments [show]
Publications
PMID: 15218032 [PubMed] Roosbeek S et al: "Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter."
No. Sentence Comment
94 Similar measurements were performed in the presence of 50 ␮M 4,5,6,7-tetrabromobenzotriazole and apigenin CK2 inhibitors on Mock-transfected and Hek-293 cells transfected with WT ABCA1 and with the T1242A, T1243A, T1242A/T1243A, and T1242D/T1243D ABCA1 mutants.
X
ABCA1 p.Thr1243Ala 15218032:94:213
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:94:228
status: NEW
Login to comment

133 In both systems we engineered several mutants designed at preventing phosphorylation by mutation either of the target threonines and serine, T1242A, T1243A, T1242A/ T1243A, S1255A, or of the downstream cluster of acidic residues, E1245Q, E1246Q, E1245Q/E1246Q.
X
ABCA1 p.Thr1243Ala 15218032:133:149
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:133:165
status: NEW
Login to comment

143 Analysis of the T1242A, T1243A, and T1242A/T1243A NBD1 mutants supports the loss of either one or two threonine phosphorylation sites in the mutated peptides, whereas the Ser-1255 site is preserved.
X
ABCA1 p.Thr1243Ala 15218032:143:24
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:143:43
status: NEW
Login to comment

159 Compared with WT ABCA1, set as 100%, the PE and PS content in the outer leaflet of the plasma membrane increased up to 130 Ϯ 14 and 123 Ϯ 8% for the T1242A mutant, 154 Ϯ 15 and 148 Ϯ 11% for the T1243A mutant, 170 Ϯ 15 and 207 Ϯ 16% for the T1242A/T1243A mutant, 141 Ϯ 11 and 136 Ϯ 10% for the S1255A mutant, and 141 Ϯ 13 and 120 Ϯ 9% for the E1245Q/E1246Q mutant, respectively (Fig. 4).
X
ABCA1 p.Thr1243Ala 15218032:159:219
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:159:284
status: NEW
Login to comment

162 The effect of the specific CK2 inhibitors 4,5,6,7-tetrabromo- benzotriazole and apigenin on the flippase activity in Hek-293 Tet-Off cells transfected with WT ABCA1 and with the T1242A, T1243A, T1242A/T1243A, S1255A, and T1242D/ T1243D mutants was consistent with the above data.
X
ABCA1 p.Thr1243Ala 15218032:162:186
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:162:201
status: NEW
Login to comment

176 TABLE I Mass spectrometric analysis of NBD1ϩR1 phosphorylation NBD1ϩR1 Tryptic peptide Molecular mass Molecular mass after beta-elimination Phosphorylated residues Da Da WT Leu-1229-Arg-1269 4542.5 4249.5 Thr-1242, Thr-1243, Ser-1255 T1242A Leu-1229-Lys-1250 2483.6 2385.9 Thr-1243 T1242A Val-1251-Arg-1272 2411.6 2313.7 Ser-1255 T1243A Leu-1229-Lys-1250 2483.1 2385.2 Thr-1242 T1243A Val-1251-Arg-1272 2411.2 2313.2 Ser-1255 T1242A/T1243A Leu-1229-Lys-1250 2356.1 2356.1 T1242A/T1243A Val-1251-Arg-1272 2411.6 2313.7 Ser-1255 S1255A Val-1251-Arg-1272 2297.7 2297.7 compared with WT ABCA1.
X
ABCA1 p.Thr1243Ala 15218032:176:342
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:176:390
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:176:445
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:176:491
status: NEW
Login to comment

177 This increase was more pronounced for the T1243A mutation either alone or in combination with the T1242A mutation, whereas the effect of the T1242A and S1255A mutants was similar.
X
ABCA1 p.Thr1243Ala 15218032:177:42
status: NEW
Login to comment

188 The T1242A and T1243A mutations either alone or in combination and the E1245Q/ E1246Q mutation, which all decrease CK2 activity, increased phospholipid and cholesterol efflux (Fig. 7, A and B).
X
ABCA1 p.Thr1243Ala 15218032:188:15
status: NEW
Login to comment

92 Similar measurements were performed in the presence of 50 òe;M 4,5,6,7-tetrabromobenzotriazole and apigenin CK2 inhibitors on Mock-transfected and Hek-293 cells transfected with WT ABCA1 and with the T1242A, T1243A, T1242A/T1243A, and T1242D/T1243D ABCA1 mutants.
X
ABCA1 p.Thr1243Ala 15218032:92:212
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:92:227
status: NEW
Login to comment

131 In both systems we engineered several mutants designed at preventing phosphorylation by mutation either of the target threonines and serine, T1242A, T1243A, T1242A/ T1243A, S1255A, or of the downstream cluster of acidic residues, E1245Q, E1246Q, E1245Q/E1246Q.
X
ABCA1 p.Thr1243Ala 15218032:131:149
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:131:165
status: NEW
Login to comment

141 Analysis of the T1242A, T1243A, and T1242A/T1243A NBD1 mutants supports the loss of either one or two threonine phosphorylation sites in the mutated peptides, whereas the Ser-1255 site is preserved.
X
ABCA1 p.Thr1243Ala 15218032:141:24
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:141:43
status: NEW
Login to comment

157 Compared with WT ABCA1, set as 100%, the PE and PS content in the outer leaflet of the plasma membrane increased up to 130 afe; 14 and 123 afe; 8% for the T1242A mutant, 154 afe; 15 and 148 afe; 11% for the T1243A mutant, 170 afe; 15 and 207 afe; 16% for the T1242A/T1243A mutant, 141 afe; 11 and 136 afe; 10% for the S1255A mutant, and 141 afe; 13 and 120 afe; 9% for the E1245Q/E1246Q mutant, respectively (Fig. 4).
X
ABCA1 p.Thr1243Ala 15218032:157:219
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:157:284
status: NEW
Login to comment

160 The effect of the specific CK2 inhibitors 4,5,6,7-tetrabromo- benzotriazole and apigenin on the flippase activity in Hek-293 Tet-Off cells transfected with WT ABCA1 and with the T1242A, T1243A, T1242A/T1243A, S1255A, and T1242D/ T1243D mutants was consistent with the above data.
X
ABCA1 p.Thr1243Ala 15218032:160:186
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:160:201
status: NEW
Login to comment

174 TABLE I Mass spectrometric analysis of NBD1af9;R1 phosphorylation NBD1af9;R1 Tryptic peptide Molecular mass Molecular mass after beta-elimination Phosphorylated residues Da Da WT Leu-1229-Arg-1269 4542.5 4249.5 Thr-1242, Thr-1243, Ser-1255 T1242A Leu-1229-Lys-1250 2483.6 2385.9 Thr-1243 T1242A Val-1251-Arg-1272 2411.6 2313.7 Ser-1255 T1243A Leu-1229-Lys-1250 2483.1 2385.2 Thr-1242 T1243A Val-1251-Arg-1272 2411.2 2313.2 Ser-1255 T1242A/T1243A Leu-1229-Lys-1250 2356.1 2356.1 T1242A/T1243A Val-1251-Arg-1272 2411.6 2313.7 Ser-1255 S1255A Val-1251-Arg-1272 2297.7 2297.7 Protein Kinase CK2 Phosphorylation Modulates ABCA1 Activity compared with WT ABCA1.
X
ABCA1 p.Thr1243Ala 15218032:174:342
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:174:390
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:174:445
status: NEW
X
ABCA1 p.Thr1243Ala 15218032:174:491
status: NEW
Login to comment

175 This increase was more pronounced for the T1243A mutation either alone or in combination with the T1242A mutation, whereas the effect of the T1242A and S1255A mutants was similar.
X
ABCA1 p.Thr1243Ala 15218032:175:42
status: NEW
Login to comment

186 The T1242A and T1243A mutations either alone or in combination and the E1245Q/ E1246Q mutation, which all decrease CK2 activity, increased phospholipid and cholesterol efflux (Fig. 7, A and B).
X
ABCA1 p.Thr1243Ala 15218032:186:15
status: NEW
Login to comment